Background illustration for clinical trials search

Migraine Clinical Trials

Browse 103 migraine clinical trials enrolling across the United States and Canada. 86 people applied to migraine studies last month. Search by city or state to find one near you.

Filter
1

Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.

for
Menstrual Migraines, Menstrual Bleeding, Menstrual Spotting
Location: Temple TX
Sponsor: Scott and White Hospital & Clinic

Sex: Female

Age: 18 - 45

Code: NCT01251263

Recruiting

Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

for
Dysmenorrhea, Headache, Migraine, Fatigue, Nausea,
Location: Sterling Heights MI
Sponsor: Pure Green

Sex: Female

Age: 21+

Code: NCT04091789

Phase2, Recruiting

Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets

for
Ticagrelor, Aspirin, Platelet Dysfunction Due to Drugs,
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT03005704

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

What is migraine?

Migraine is a brain condition, not a blood vessel problem or a stress reaction. An attack usually brings throbbing pain on one side of the head, along with nausea and sensitivity to light and sound, and it can last from a few hours to three days. About 1 in 4 people with migraine get an aura first, visual disturbances like flashing lights or zigzag lines that come before the pain. Doctors sort migraine by frequency: episodic means fewer than 15 headache days a month, chronic means 15 or more, with at least 8 of them migraine days, for more than three months.

For most of medical history, migraine was treated with medicines borrowed from other conditions: blood pressure pills, antidepressants, epilepsy drugs. That changed in 2018, when the first medicine designed specifically for migraine was approved. It blocks a molecule called CGRP, which the brain releases during an attack. There are now four CGRP antibodies given by injection and several CGRP blocking pills, called gepants, and they treat both attacks and prevention. In a 2025 real world study of more than 2,000 patients, about 47 percent of people on a CGRP antibody had a meaningful response at three months, compared with about 35 percent on traditional preventives.

Types of migraine clinical trials

Who can participate in migraine clinical trials?

Episodic and chronic migraine, and why the line matters for trials

Do migraine trial participants get paid?

What is the difference between a migraine and a headache?

How to Enroll in a Clinical Trial for Migraine